AR038028A1 - Derivados de benzotiazina y benzotiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents

Derivados de benzotiazina y benzotiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Info

Publication number
AR038028A1
AR038028A1 ARP020104932A ARP020104932A AR038028A1 AR 038028 A1 AR038028 A1 AR 038028A1 AR P020104932 A ARP020104932 A AR P020104932A AR P020104932 A ARP020104932 A AR P020104932A AR 038028 A1 AR038028 A1 AR 038028A1
Authority
AR
Argentina
Prior art keywords
benzotiadiazine
benzotiazine
derivatives
pharmaceutical compositions
compositions containing
Prior art date
Application number
ARP020104932A
Other languages
English (en)
Inventor
Alex Cordi
Patrice Desos
Pierre Lestage
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038028A1 publication Critical patent/AR038028A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos de fórmula (1) en la cual R1 representa en arilo o heteroarilo, R2 representa un H, halógeno, un hidroxi; A representa CR4R5, o NR4; R3 representa H, alquilo o cicloalquilo, R4 representa un H, o un alquilo; o bien A representa un N y forma con -CHR3 adyacente, el ciclo de fórmula (2), en el cual m representa 1, 2, ó 3, R5 representa un H, o halógeno, sus isómeros, así como sus sales de adición. Medicamentos útiles como moduladores de AMPA .
ARP020104932A 2001-12-21 2002-12-18 Derivados de benzotiazina y benzotiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen AR038028A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116621A FR2833956B1 (fr) 2001-12-21 2001-12-21 Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR038028A1 true AR038028A1 (es) 2004-12-22

Family

ID=8870809

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104932A AR038028A1 (es) 2001-12-21 2002-12-18 Derivados de benzotiazina y benzotiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Country Status (21)

Country Link
US (1) US7253161B2 (es)
EP (1) EP1480986A1 (es)
JP (1) JP2005518386A (es)
KR (1) KR100586685B1 (es)
CN (1) CN1289509C (es)
AR (1) AR038028A1 (es)
AU (1) AU2002364674B2 (es)
BR (1) BR0214973A (es)
CA (1) CA2471263A1 (es)
EA (1) EA007227B1 (es)
FR (1) FR2833956B1 (es)
GE (1) GEP20063759B (es)
HU (1) HUP0402585A3 (es)
MA (1) MA27090A1 (es)
MX (1) MXPA04005837A (es)
NO (1) NO20042978L (es)
NZ (1) NZ533328A (es)
PL (1) PL370159A1 (es)
UA (1) UA77737C2 (es)
WO (1) WO2003053979A1 (es)
ZA (1) ZA200404294B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856064B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2856065B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2877342B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2877338B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2955106B1 (fr) * 2010-01-08 2011-12-23 Servier Lab Nouveaux derives de benzothiadiazines cyclopropylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US9493484B2 (en) 2012-02-08 2016-11-15 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
EP3693360B1 (en) 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
CN107641197B (zh) * 2017-10-30 2019-11-22 河南工程学院 一种以二氧化碳与环氧环己烷为单体的共聚反应催化剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
CA2320354A1 (en) * 1998-02-18 1999-08-26 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
FR2812291B1 (fr) * 2000-07-28 2002-12-13 Adir Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HK1071749A1 (en) 2005-07-29
AU2002364674A1 (en) 2003-07-09
CN1289509C (zh) 2006-12-13
US20050124606A1 (en) 2005-06-09
HUP0402585A3 (en) 2009-01-28
GEP20063759B (en) 2006-02-27
US7253161B2 (en) 2007-08-07
KR20040073480A (ko) 2004-08-19
NO20042978L (no) 2004-07-14
ZA200404294B (en) 2005-06-01
HUP0402585A2 (hu) 2005-03-29
MXPA04005837A (es) 2004-09-10
FR2833956B1 (fr) 2004-01-30
CA2471263A1 (fr) 2003-07-03
MA27090A1 (fr) 2004-12-20
EP1480986A1 (fr) 2004-12-01
AU2002364674B2 (en) 2007-11-22
FR2833956A1 (fr) 2003-06-27
JP2005518386A (ja) 2005-06-23
EA007227B1 (ru) 2006-08-25
EA200400758A1 (ru) 2005-06-30
KR100586685B1 (ko) 2006-06-08
BR0214973A (pt) 2004-12-14
CN1606560A (zh) 2005-04-13
PL370159A1 (en) 2005-05-16
WO2003053979A1 (fr) 2003-07-03
UA77737C2 (en) 2007-01-15
NZ533328A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
UY28290A1 (es) Compuestos farmacéuticos novedosos
AR039789A1 (es) Pirazolopiridinas sustituidas con carbamato
ECSP034831A (es) Derivados sustituidos de la 2-piridina ciclohexano-1,4-diamina
NI201000022A (es) Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparación, su aplicación como medicamentos, composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
CY1111843T1 (el) 2-υποκατεστημενα αναλογα βιταμινης d και θεραπευτικες χρησεις αυτων
PA8592001A1 (es) Activadores de glocoquinasa heteroaromaticos de seis miembros 5-sustituidos
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
UY28625A1 (es) Nuevos compuestos farmacéuticos
ECSP066667A (es) Derivados de ciclohexano espirociclicos
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
ES2189365T3 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
GT200000049A (es) Compuestos quimicos.
NO20054787D0 (no) Indenderivater som farmasotiske midler
PA8589801A1 (es) Aminoalcoxiindoles
AR039172A1 (es) Derivados de morfolina, antagonistas de ccr3.
AR038842A1 (es) Derivados de artemisinina (endoperoxidos) antiparasitarios
AR044671A1 (es) Compuestos de benzotiazina y benzotiadiazina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
ES8403473A1 (es) Procedimiento para la obtencion de derivados de n-(benzotiofenmetil)-n-metil-het-2-en-4-in-amina.
AR056528A1 (es) Derivados de bencimidazoles y benzotiazoles su proceso de preparacion su aplicacion como medicamentos composiciones farmaceuticas y utilizacion principalmente como inhibidores de cmet
AR034313A1 (es) Utilizacion de derivados de piridoindolona para la preparacion de medicamentos

Legal Events

Date Code Title Description
FB Suspension of granting procedure